1 February 2022
Living Cell Technologies Ltd (LCT)LCT:ASX • Healthcare
52 WEEK RANGE
0.005 - 0.018
1 YR RETURN
Novel therapies for serious diseases
LCT is an Australasian biotechnology company improving the wellbeing of people with serious diseases by discovering, developing and commercialising novel treatments for debilitating conditions such as Parkinson’s disease, obesity and migraine.
Our product candidates leverage the potential of cells and their receptors to address serious conditions that have an unmet need for effective treatments.
We are listed on both the Australian Securities Exchange (ASX:LCT) and the international OTCQB (LVCLY). Share registry services are provided by Automic.